Strategy for improved characterization of human metabolic phenotypes using a COmbined Multi-block Principal components Analysis with Statistical Spectroscopy (COMPASS).


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
29 01 2021
Historique:
received: 29 03 2020
revised: 13 06 2020
accepted: 15 07 2020
pubmed: 22 7 2020
medline: 10 8 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

Large-scale population omics data can provide insight into associations between gene-environment interactions and disease. However, existing dimension reduction modelling techniques are often inefficient for extracting detailed information from these complex datasets. Here, we present an interactive software pipeline for exploratory analyses of population-based nuclear magnetic resonance spectral data using a COmbined Multi-block Principal components Analysis with Statistical Spectroscopy (COMPASS) within the R-library hastaLaVista framework. Principal component analysis models are generated for a sequential series of spectral regions (blocks) to provide more granular detail defining sub-populations within the dataset. Molecular identification of key differentiating signals is subsequently achieved by implementing Statistical TOtal Correlation SpectroscopY on the full spectral data to define feature patterns. Finally, the distributions of cross-correlation of the reference patterns across the spectral dataset are used to provide population statistics for identifying underlying features arising from drug intake, latent diseases and diet. The COMPASS method thus provides an efficient semi-automated approach for screening population datasets. Source code is available at https://github.com/cheminfo/COMPASS. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 32692809
pii: 5874439
doi: 10.1093/bioinformatics/btaa649
pmc: PMC7850059
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5229-5236

Subventions

Organisme : NHLBI NIH HHS
ID : R01-HL50490
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL135486
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Auteurs

Ruey Leng Loo (RL)

Centre for Computational and Systems Medicine, Perth, WA 6150, Australia.
The Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia.

Queenie Chan (Q)

Department of Epidemiology and Biostatistics, London W2 1PG, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK.

Henrik Antti (H)

Department of Chemistry, Umea Universitet, 901 87 Umeå, Sweden.

Jia V Li (JV)

Department of Surgery and Cancer, Imperial College London, London W2 1PG, UK.

H Ashrafian (H)

Department of Surgery and Cancer, Imperial College London, London W2 1PG, UK.

Paul Elliott (P)

Department of Epidemiology and Biostatistics, London W2 1PG, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK.

Jeremiah Stamler (J)

Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Jeremy K Nicholson (JK)

Centre for Computational and Systems Medicine, Perth, WA 6150, Australia.
The Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia.

Elaine Holmes (E)

Centre for Computational and Systems Medicine, Perth, WA 6150, Australia.
The Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, WA 6150, Australia.
Department of Surgery and Cancer, Imperial College London, London W2 1PG, UK.

Julien Wist (J)

Chemistry Department, Universidad del Valle, Cali, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH